%0 Journal Article 
%A Rand, K.
%A Ramos-Goñi, J. M.
%A Akmaz, B.
%A Solé-Feu, L.
%A Armario Hita, José Carlos
%T Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”
%D 2024
%@ 2190-9172

%U http://hdl.handle.net/10498/32774
%X Letter
%~ Universidad de Cádiz